2018 IPO

Guardant Health Stock

Bio-tech company focus on oncology

Sign up today and learn more about Guardant Health Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2012

Notable Investors

Sequoia Capital

Headquarters

Redwood City CA, US

Total Funding

$515M

About Guardant Health Stock

Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Investors

Funding History

April 2013$9.2M
April 2014$32.6M
December 2014$56.0M
December 2015$83.9M
May 2017$334M

Management

Chief Executive Officer

Helmy Eltoukhy

Chief Financial Officer

Derek Bertocci

Chief Legal Officer

Michael Wiley

Chief Medical Officer

Richard Lanman

COO & President

AmirAli Talasaz

VP of Marketing

Sandra Finley

Head of Sales

Stanley Welle

VP of Bioinformatics

Darya Chudova

Vice President, Pharma Business Development

Daniel Simon

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo